These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. Clinical review: a systematic review of corticosteroid use in infections. Aberdein J; Singer M Crit Care; 2006 Feb; 10(1):203. PubMed ID: 16356204 [TBL] [Abstract][Full Text] [Related]
104. Glucocorticosteroids for viral hepatitis C. Brok J; Mellerup MT; Krogsgaard K; Gluud C Cochrane Database Syst Rev; 2004; 2004(2):CD002904. PubMed ID: 15106184 [TBL] [Abstract][Full Text] [Related]
105. Aminoadamantanes for chronic hepatitis C. Lamers MH; Broekman M; Drenth JP; Gluud C Cochrane Database Syst Rev; 2014 May; 2014(5):CD010125. PubMed ID: 24793264 [TBL] [Abstract][Full Text] [Related]
106. Aminoadamantanes versus other antiviral drugs for chronic hepatitis C. Lamers MH; Broekman M; Drenth JP; Gluud C Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD011132. PubMed ID: 24937404 [TBL] [Abstract][Full Text] [Related]
107. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791 [TBL] [Abstract][Full Text] [Related]
108. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis. Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011644. PubMed ID: 28285495 [TBL] [Abstract][Full Text] [Related]
109. Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Fabris P; Floreani A; Tositti G; Vergani D; De Lalla F; Betterle C Aliment Pharmacol Ther; 2003 Sep; 18(6):549-58. PubMed ID: 12969081 [TBL] [Abstract][Full Text] [Related]
110. Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy. Fabbri C; Jaboli MF; Giovanelli S; Azzaroli F; Pezzoli A; Accogli E; Liva S; Nigro G; Miracolo A; Festi D; Colecchia A; Montagnani M; Roda E; Mazzella G World J Gastroenterol; 2003 Jul; 9(7):1487-90. PubMed ID: 12854147 [TBL] [Abstract][Full Text] [Related]
111. Management of hepatitis C. Alberti A; Benvegnù L J Hepatol; 2003; 38 Suppl 1():S104-18. PubMed ID: 12591189 [No Abstract] [Full Text] [Related]
112. Extrahepatic manifestations of hepatitis C among United States male veterans. El-Serag HB; Hampel H; Yeh C; Rabeneck L Hepatology; 2002 Dec; 36(6):1439-45. PubMed ID: 12447870 [TBL] [Abstract][Full Text] [Related]
113. Ribavirin with or without alpha interferon for chronic hepatitis C. Kjaergard LL; Krogsgaard K; Gluud C Cochrane Database Syst Rev; 2002; (2):CD002234. PubMed ID: 12076442 [TBL] [Abstract][Full Text] [Related]
114. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Gotzsche PC; Johansen HK Cochrane Database Syst Rev; 2002; (2):CD000189. PubMed ID: 12076385 [TBL] [Abstract][Full Text] [Related]